$79.90
-0.20-0.25%
Last update: Oct 16, 6:40 PM
$79.00
-1.10-1.37%
Spyre Therapeutics Inc
SYRENASDAQ
Wall Street analyst price targets and consensus rating for Spyre Therapeutics (SYRE).
Price Target Range — 12 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months
